MIPI
Case 59: Immune Checkpoint Inhibitor - Nivolumab - Lung Injury / ILD and Recognizing Pre-Existing ILA/ILD Paid Members Public
Immune checkpoint inhibitor lung injury is not uncommon and needs to be recognized
Case 46: The Discordance Between Surgeons and Physicians Paid Members Public
A good history helps us identify etiologies of reversible ILDs
